LoginSignup
ECI

EIS Stock

StockStock
ISIN: TRAECILC91E0
Ticker: ECILC.E
TRAECILC91E0
ECILC.E

Price

Historical dividends and forecast

All dividend data

EIS has so far distributed $0.0365 in 2024. The next dividend will be paid on 07.06.2025

$0.0298

CHART BY

Frequently asked questions

What is EIS's market capitalization?

The market capitalization of EIS is $853.19M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is EIS's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for EIS is 8.15. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for EIS?

EIS's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.153. EPS indicates the company's profitability on a per-share basis.

What is EIS's revenue over the trailing twelve months?

Over the trailing twelve months, EIS reported a revenue of $266.23M.

What is the EBITDA for EIS?

EIS's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $23.41M. EBITDA measures the company's overall financial performance.

What is the free cash flow of EIS?

EIS has a free cash flow of -$46.57M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of EIS's stock?

The 5-year beta for EIS is 0.90. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does EIS have, and what sector and industry does it belong to?

EIS employs approximately 1,096 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of EIS's shares?

The free float of EIS is 128.61M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $853.19M

5Y beta

 0.90

EPS (TTM)

 $0.153

Free Float

 128.61M

P/E ratio (TTM)

 8.15

Revenue (TTM)

 $266.23M

EBITDA (TTM)

 $23.41M

Free Cashflow (TTM)

 -$46.57M

Information

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS, formerly known as Eczacibasi Ilac Sanayi ve Ticaret A.S., (EIS) is a Turkey-based company active in the pharmaceutical industry through its subsidiaries, affiliates and joint ventures. Its product portfolio consists of drugs for human health, veterinary drugs and personal care products, such as body and facial creams, hair gels, deodorants and various other products. The Company is also engaged in real estate development and construction through its subsidiary, Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., formerly known as Eczacibasi Insaat ve Ticaret A.S. Its subsidiaries also include Eczacibasi Ilac Ticaret A.S. (EIT), EHP Eczacibasi Health Care Products Joint Stock Co. (EHP), and Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., among others. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a member of Eczacibasi Group of Companies.

1,096

Biotechnology & Drugs

Health Care

Identifier

ISIN

TRAECILC91E0

Primary Ticker

ECILC.E
Join the conversation
Sign upLogin